Merck to Acquire Idenix Pharmaceuticals ANDREW POLLACK Merck will pay $24.50 in cash for the biotechnology company in an effort to bolster its arsenal of potential drugs in the hotly competitive hepatitis C area. June 9, 2014 at 4:00AM http://nyti.ms/1kZRQhO The New York Times Business Day

By ANDREW POLLACK via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1kZRQhO Merck to Acquire Idenix Pharmaceuticals June 9, 2014 at 4:00AM The New York Times